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Decompressive hemicraniectomy (DHC) for malignant middle cerebral 
artery (MCA) infarction has been shown to reduce mortality and improve 
functional outcomes in young adults; however, there is currently debate 
regarding how routinely such surgery should be performed in the clinical 
setting, considering the very high rate of disability and functional 
dependence among survivors. We herein report the current status of the 




We retrospectively studied of cohort cases of DHC for malignant MCA 
infarction treated at pivotal teaching neurosurgical departments in Japan 
between January 2011 and December 2011. Information was obtained 
regarding patient characteristics, radiological features and outcomes during 
follow-up. The endpoints included 30-day mortality rate and functional 
outcomes, as measured according to the modified Rankin scale (mRS) 




Three hundred and fifty-five patients underwent DHC at 259 neurosurgical 
departments who replied to the survey, corresponding to a rate of 8.7% of 
the 4,092 candidates with malignant MCA infarction, the latter being 
equivalent to 8.5% of patients with acute ischemic stroke identified during 
the same period. Among the patients undergoing DHC, the mean age was 
67.0 years, and those ≥60 years of age comprised 80.2% of all DHC 
patients. The most frequently used modality for vascular imaging was 
magnetic resonance angiography (77.2%). DHC was generally performed 
between 24-48 hours after onset (38.9%), with 36.9% of patients 
undergoing surgery at ≥48 hours. At the time of surgery, 26.1% of the 
patients had a Glasgow coma scale (GCS) score of ≤6. Pre-surgical 
2 
midbrain compression was noted in 52.1% of the patients. The 30-day 
mortality after DHC was 18.6%, and factors affecting death were a GCS 
score of ≤6 (OR 1.88, 95%CI 1.05-3.32, P=0.03) and midbrain 
compression (OR 2.28, 95%CI 1.31-4.09, P=0.005). According to the 
multivariate analysis, only midbrain compression was an independent risk 
factor (OR 2.12, 95% CI 1.16-3.95, P=0.01) for 30-day mortality. Modified 
Rankin scale scores at three months were available in 175 patients (49.3%), 
only 5.2% of whom exhibited a favorable functional outcome (mRS score 
≤3). Meanwhile, 22.9% of the patients had an mRS score of 4, 26.9% had 
an mRS score of 5 and 45.1% were found to have died.  
 
CONCLUSIONS:   
In the present study, less than one-tenth of candidates with malignant MCA 
infarction in Japan underwent decompressive surgery, and the vast majority 
of patients were elderly. Age was not found to be an independent factor for 
immediate mortality in this study, and performing surgery in the elderly 
may be justified based on additional evidence of functional improvements.   
 
 
INTRODUCTION    
 
   Malignant middle cerebral artery (MCA) infarction is characterized by 
the development of life-threatening space-occupying cerebral edema 
complicating large MCA infarction and is widely used as a category for 
subgrouping stroke patients (6, 11, 14, 20, 25). Despite the scarcity of 
scientific evidence indicating its benefits in such patients, the use of 
decompressive hemicraniectomy (DHC) is well established and the 
frequency of this procedure has gradually increased (1, 11). Recent 
European randomized controlled trials (RCTs) have demonstrated that the 
use of DHC in cases of malignant MCA infarction reduces mortality and 
improves functional outcomes in young adults (10, 12, 22, 23). However, 
the application of decompressive surgery has not been fully characterized 
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with respect to how routinely it should be performed in the clinical setting, 
considering the very high rate of disability and functional dependence 
among survivors (6, 17, 20, 25). 
   In order to clarify the current status of such decompressive surgery in 
Japan, we surveyed patients who underwent DHC in 2011 using a 
questionnaire distributed to pivotal training neurosurgical departments. We 
herein report the present status of this treatment in Japan and compare the 
published literature on immediate outcomes after DHC in order to evaluate 
the efficacy of early decompressive surgery. 
 
 
METHODS    
 
   In 2011, there were 556 pivotal teaching departments of neurosurgery 
containing at least three members of the Japanese Society of Neurosurgery 
in Japan. We sent each of these departments questionnaires in February 
2012, including letters of request for participation, survey slips and a 
request for reports of the following between January 2011 and December 
2011; the number of patients with acute ischemic stroke; the number of 
patients having undergone DHC for malignant MCA infarction, excluding 
cases of subarachnoid hemorrhage, intracerebral hemorrhage, head trauma 
and cerebellar infarction; the number of patients not treated with DHC for 
malignant MCA infarction; reasons for not performing DHC; demographics 
of the patients treated with DHC, such as age, National institutes of health 
stroke scale (NIHSS) score on admission, the level of consciousness before 
surgery, timing of surgery, modality of vascular imaging, pre-surgical 
radiological findings on computed tomography (CT) or magnetic resonance 
(MR) imaging, 30-day mortality and functional outcomes as determined 
according to the modified Rankin scale (mRS) score at three months after 
DHC. 
   The clinical diagnosis of malignant MCA infarction was made 
according to the definition used in recent RCTs (22): 1) clinical signs of 
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large MCA territory infarction with an NIHSS score of >18 and a level of 
consciousness of ≥1 on item 1a of the NIHSS either on admission or after 
secondary deterioration; 2) the presence of large space-occupying MCA 
infarcts on follow-up MR imaging or CT of at least half of the MCA 
territory with compression of ventricles or midline shift; and 3) the lack of 
other obvious causes of neurological deterioration. The timing of the 
initiation of DHC depended on the department, i.e. regardless of the 
presence of signs of clinical cerebral herniation, such as papillary dilatation, 
or hemorrhagic infarction, as shown in the radiological findings. 
   Factors affecting the 30-day mortality rate after DHC were statistically 
analyzed with logistic regression models using the JMP 9.0 software 
program (SAS Institute Inc., Cary, North Caroline, USA), and the odds 
ratio (OR) and 95% confidence interval (CI) were obtained. Variables were 
considered for the multivariable models if their univariate P value was less 




RESULTS   
 
   Among the 556 neurosurgical departments, 259 replied, for a response 
rate of 46.6%, and a total of 48,369 acute ischemic stroke patients were 
identified, with a median number of 151 and an interquartile range (IQR) of 
55-271, between January 2011 and December 2011 (Figure 1). There were 
3,737 patients with malignant MCA infarction who did not undergo DHC 
in these departments, ranging from 0 to 148, with a median number of 9 
(IQR 3-17). Reasons for not performing DHC, as indicated by family 
members, included an advanced age (72%), concern regarding the efficacy 
of the procedure (65%) and the presence of infarction in the dominant 
hemisphere (33%), with overlapping results.  
 
Demographics of the patients undergoing surgery 
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   A total of 355 patients (59% male, 41% female) treated with DHC for 
malignant MCA infarction were reported among 259 neurosurgical 
departments, ranging from 0 to 14, with a median number of 1 (IQR 0-2) 
(Figure 2). Therefore, a total of 4,092 patients with malignant MCA 
infarction (8.5%) among 48,369 patients with acute ischemic stroke 
identified during the same period were considered candidates for DHC, 
only 8.7% of whom underwent surgery. Among the patients undergoing 
DHC, the mean age ± standard deviation (SD) was 67.0 ± 11.5 years, with 
a median 69 of years (IQR 61-75), and those ≥60 years of age comprised 
80.2% of all DHC patients (Figure 3). The NIHSS score on admission 
ranged from 0 to 38, with a median value of 18 (IQR 14-22) (Figure 4). A 
total of 257 patients had right-sided infarction (73.0%), 203 patients had 
ipsilateral internal carotid artery (ICA) occlusion (57.2%), 213 patients had 
arterial fibrillation (60.0%), 90 patients underwent the intravenous injection 
of tissue plasminogen activator (t-PA) (25.4%) and 56 patients received 
endovascular treatment (15.8%). The primary modality of vascular imaging 
was as follows; MR angiography=77.2%, conventional 
angiography=18.6%, CT angiography=16.9%, ultrasound 
sonography=7.0%, with overlapping results. 
 
Time to surgery from symptom onset  
 
   DHC was generally performed (38.9%) between 24-48 hours after 
symptom onset (Figure 5). In addition, 131 patients (36.9%) underwent 
surgery ≥48 hours of onset. At the time of surgery, 194 patients (54.7%) 
exhibited a Glasgow coma scale (GCS) score of ≤6 with or without signs of 
clinical herniation. Pre-surgical compression of the midbrain was observed 
on CT or MR images in 185 patients (52.1%). 
 
30-day mortality and functional outcomes at three months  
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   Sixty-six of the 355 patients died within 30 days of DHC (18.6%). 
According to the univariate analysis, factors associated with death after 
DHC included a GCS score of ≤6 (OR 1.88, 95%CI 1.05-3.32, P=0.03) and 
midbrain compression on CT/MR imaging (OR 2.28, 95%CI 1.31-4.09, 
P=0.005) (Table 1). The presence of atrial fibrillation was found to be 
inversely correlated with mortality (OR 0.53, 95% CI 0.30-0.93, P=0.03). 
According to the multivariate analysis, only midbrain compression was an 
independent risk factor (OR 2.12, 95% CI 1.16-3.95, P=0.01) for 30-day 
mortality after DHC.  
   Modified Rankin scale (mRS) scores at three month were available in 
175 patients (49.3%); only 5.2% of the patients achieved a favorable 
functional outcome (mRS score ≤3), whereas 22.9% had an mRS score of 4, 





   
DISCUSSION   
 
Frequency of decompressive hemicraniectomy in Japan 
 
   In this study, we obtained data regarding DHC performed in 2011 at 
pivotal training neurosurgical departments in Japan. A total of 355 cases of 
DHC among 48,369 cases of acute ischemic stroke were reported, 
suggesting that 0.73% of acute ischemic patients underwent DHC at these 
departments. The prevalence of DHC is somewhat higher than the adjusted 
prevalence of 0.51% observed in acute ischemic stroke patients, based on 
the Diagnosis Procedure Combination data provided by the Ministry of 
Health, Labour and Welfare of Japan, which reported 632 decompressive 
craniectomy procedures (code 1492) among 123,427 patients with acute 
ischemic stroke (code 010060) between July 2010 and May 2011 in Japan. 
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Regardless of the problems associated with this procedure, such as 
complications, including cerebellar infarction, and excluding fee-for 
service payments, these data are trustworthy and the present data 
approximated these findings. On the other hand, the incidence of malignant 
MCA infarction in the present study was 8.5% among acute ischemic 
stroke patients, and only 8.7% of patients considered to be candidates 
underwent decompressive surgery during the same period. 
   In a nationwide study in the US, only 0.07% of acute ischemic stroke 
patients were reported to have received decompressive surgery in 
2005-2008 (2); however the frequency of DHC increased linearly by 21% 
per year, regardless of the additive effects after publication of the pooled 
analysis for DHC in 2007. In another report (8), urban teaching hospitals 
were considered to be responsible for the increase in the frequency of DHC 
from 0.05% in 2001 to 0.3% in 2009 among a US nationwide inpatient 
sample. In addition, trends in increased utilization were found to be greatest 
among younger patients (age<45 years) and males (8). The relatively high 
frequency of DHC in Japan may be due, at least in part, to the ready 
availability of MR imaging, thus facilitating the prediction of malignancy 
of MCA infarction, as the usefulness of MR imaging performed within six 
hours of onset in predicting progression to malignant MCA infarction has 
been reported, in contrast to the NIHSS score on admission, which fails to 
predict such progression (21). In a report from the Czech Republic, the 
procedure remained underutilized, as less than 10% of those who required 
decompression underwent surgery, with a frequency similar to our results 
(7). 
 
Characteristics of patients undergoing decompressive 
hemicraniectomy  
 
   Among the patients undergoing DHC in this study, the median NIHSS 
score on admission was 18 (IQR 14-22), the condition exhibited a 
right-side predominance (73.0%) and the presence of ipsilateral ICA 
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occlusion was detected in 57.2% of patients, although these were not found 
to be independent factors affecting the 30-day mortality. Interestingly, the 
occurrence of atrial fibrillation (60.0%) was found to be inversely 
correlated with mortality, although this finding did not reach statistical 
significance in the multivariate analysis. The administration of intravenous 
thrombolysis and/or endovascular treatment also did not affect immediate 
mortality after DHC. In this study, 18.6% of the patients died within 30 
days after undergoing DHC, and only 5.2% of patients exhibited a 
favorable functional outcome (mRS score ≤3) at three months after DHC.   
   Published reports suggest that a poor outcome may be attributable to 
the presence of herniation, a low preoperative level of consciousness and 
the involvement of multiple vascular territories in ischemic stroke patients 
(6, 10, 15, 20). In a meta-analysis of three RCTs, DHC performed within 48 
hours of ictus reduced the mortality rate from 71% to 22% and doubled the 
probability of a favorable functional outcome (mRS ≤3) at one year after 
surgery (22). Because we only evaluated 30-day mortality, we cannot 
compare our findings with these data. In addition, the present subjects 
included many elderly patients (median age: 69), and 36.9% of the patients 
underwent surgery ≥48 hours after symptom onset, which do not 
correspond to the inclusion criteria used in recent RCTs (22).  
 
Time limitations   
 
   Brain edema following MCA territorial infarction often peaks 48 hours 
after symptom onset, and the use of delayed surgery (48-96 hours) in recent 
RCTs has not been demonstrated to reduce mortality, although these studies 
were limited by a small number of patients (10). On the other hand, the 
efficacy of immediate surgery within 24 hours does not differ from that of 
surgery performed with 24-48 hours in terms of the likelihood of a 
functional recovery after the procedure (22). In the present study, DHC was 
generally performed (38.9%) between 24-48 hours of onset, and 36.9% of 
the patients underwent surgery ≥48 hours after symptom onset. The timing 
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of surgery was not found to be an independent factor affecting 30-day 
mortality, whereas a trend was observed toward decreased mortality, 
although it did not reach statistical significance (P=0.07). Patients in which 
brain edema develops after 48 hours may be more tolerant to the same 
degree of ischemic insult due to the presence of a preexisting or developing 
collateral circulation than those in whom such symptoms emerge before 48 
hours, and additional predictors should be elucidated in future studies. 
 
Age limitations   
 
   Another concern is whether performing decompression surgery in 
elderly patients with malignant MCA infarction can be used to reduce 
mortality and improve functional outcomes, as it has been shown that 
elderly patients have a statistically higher rate of mortality and poor 
functional outcomes after DHC than young patients (5, 9). As to in-hospital 
mortality, the rate observed among elderly patients after this procedure may 
be higher (24), while other studies have reported that age as well as sex, 
thrombolysis, and the occurrence of stroke-related complications, such as 
aspiration pneumonia, do not affect in-hospital mortality, although the 
patients undergoing DHC (mean age: 55.6 years) in these studies exhibited 
a higher rate (32.1%) of mortality than conservatively treated acute 
ischemic stroke patients (4). In a systematic review incorporating a wide 
range in age and hours from ictus to surgery, an age over 60 years (P<0.05) 
as well as additional cerebral artery involvement and a greater midline shift 
preoperatively were found to be independent factors affecting 30-day 
mortality after DHC (15). In the present study, it is interesting to note that 
the most frequent reason for not performing DHC, as indicated by family 
members, was an advanced age, while patients ≥60 years of age comprised 
80.2% of all DHC patients (median: 69, IQR: 61-75). In addition, we did 
not find any evidence of a higher immediate mortality rate among elderly 
patients after DHC for malignant MCA infarction. Because elderly patients 
(aged >60) were excluded in recent RCTs (12, 22, 23), the indications for 
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performing this procedure in elderly subjects have not been justified, and 
the underutilization of DHC is a current problem (11, 17). Whether the 
application of DHC in the management of malignant MCA infarction in 
elderly patients is meaningful or equivalent to that observed in young 
adults should be evaluated, and new RCTs are currently underway (13, 16, 
26).  
 
Study Limitations   
 
   There are several limitations associated with the present study. First, 
because the data for small hospitals with two or fewer neurosurgeons were 
not included, the actual frequency of DHC could not be assessed. In 
addition, the information for the patients with acute ischemic stroke in this 
study was obtained in combination with the departments of neurology and 
neurosurgery; therefore, the results are representative, at least regarding the 
trends in the frequency of and indications for DHC for malignant MCA 
infarction in Japan. Second, the characteristics of the patients treated with 
and without DHC were not directly compared. In addition, the mortality of 
patients was calculated only at one month after DHC, and the functional 
outcomes at three months in survivors were not statistically evaluated. 
Among elderly patients, who comprised the majority of subjects in this 
study, the greatest concern is regarding a functional recovery, while 
hemispheric dominance does not affect mortality (11, 22). DHC increases 
the probability of achieving an mRS score of 4 at one year, although 
whether this indicates a favorable outcome has not reached a consensus (18, 
22), as patients with non-speech dominant hemispheric infarction treated 
with DHC are possibly at high risk of depression and severe cognitive 
impairment (19). In this study, as a large number of patients were lost to 
follow-up after being transferred from each department, we were unable to 
obtain results regarding functional assessments at six months after DHC in 
order to provide data comparable to those reported in recent RCTs (12, 22, 
23). The non-significant mortality observed at one month after DHC in the 
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elderly may be attributable to the selected definition of this concept. 
Nevertheless, we believe that our study clearly outlines the current status of 
DHC in the acute stage of malignant MCA infarction in Japan and indicates 
ongoing problems, especially with respect to the application of this 
procedure in the elderly. 
 
CONCLUSIONS   
 
   The present study demonstrated the current status of DHC for 
malignant MCA infarction in Japan. Only 8.5% of candidates with 
malignant MCA infarction underwent decompressive surgery, and the vast 
majority of patients were ≥60 years of age. DHC was found to be 
underutilized and performed mostly in patients not meeting eligibility 
criteria for the procedure based on that reported in recent RCTs (12, 22, 23). 
Although age was not found to be an independent factor for immediate 
mortality in this study, performing surgery in the elderly may be justified 
by additional evidence regarding the ability to obtain functional 
improvements, considering the high rate of physical disability observed 
among survivors. Further studies are required to determine the proper 
utilization of such procedures by evaluating appropriate quality-of-life 
measurements and functional outcome parameters. 
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Distribution of the Number of Patients Undergoing Decompressive 
Hemicraniectomy for Malignant Middle Cerebral Artery Infarction 
DHC, decompressive hemicraniectomy 
 
Figure 3 




National Institutes of Health Stroke Scale Score on Admission in the 
Patients Undergoing Decompressive Hemicraniectomy 
NIHSS, National institutes of health stroke scale 
 
Figure 5 
Time to Decompressive Hemicraniectomy from Symptom Onset 
DHC, decompressive hemicraniectomy 
 
Table 1 
Factors Affecting the 30-day Mortality Rate after Decompressive 
Hemicraniectomy for Malignant Middle Cerebral Artery Infarction 
According to the Univariate and Multivariate Analyses 
OR, odds ratio; CI, confidence interval; ICA, internal carotid artery; t-PA, 
tissue plasminogen activator; NIHSS, National institutes of health stroke 
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Univariate Analysis Multivariate Analysis
OR (95% CI) P Value OR (95% CI) P Value
Age 0.99 (0.98-1.03) 0.56
Age, ≥60 vs. <60 years 1.02 (0.54-2.07) 0.95
Sex, M vs. F 1.49 (0.86-2.65) 0.16 1.46 (0.80-2.73) 0.22
Infarcted side, R vs. L 1.16 (0.64-2.22) 0.63
Ipsilateral ICA occlusion 0.97 (0.55-1.71) 0.91
Atrial fibrillation 0.53 (0.30-0.93) 0.03 0.55 (0.30-1.01) 0.05
Use of t-PA 1.63 (0.90-2.88) 0.11 1.59 (0.84-2.98) 0.15
Endovascular treatment 1.40 (0.68-2.73) 0.34
Surgery ≥48 hours of onset 0.58 (0.32-1.04) 0.07 0.56 (0.29-1.04) 0.07
NIHSS on admission ≥15 0.93 (0.53-1.63) 0.79
NIHSS on admission ≥20 1.43 (0.82-2.48) 0.19 1.43 (0.79-2.55) 0.23
GCS ≤6 before surgery 1.88 (1.05-3.32) 0.03 1.50 (0.88-2.79) 0.20
Midbrain compression 2.28 (1.31-4.09) 0.005 2.12 (1.16-3.95) 0.01
Table 1
